Literature DB >> 19854189

Cocaine- and amphetamine-regulated transcript mediates the actions of cholecystokinin on rat vagal afferent neurons.

Guillaume De Lartigue1, Rod Dimaline, Andrea Varro, Helen Raybould, Claire Barbier De la Serre, Graham J Dockray.   

Abstract

BACKGROUND & AIMS: Cholecystokinin (CCK) acts on vagal afferent neurons to inhibit food intake and gastric emptying; it also increases expression of the neuropeptide cocaine- and amphetamine-regulated transcript (CART), but the significance of this is unknown. We investigated the role of CARTp in vagal afferent neurons.
METHODS: Release of CART peptide (CARTp) from cultured vagal afferent neurons was determined by enzyme-linked immunosorbent assay. Expression of receptors and neuropeptides in rat vagal afferent neurons in response to CARTp was studied using immunohistochemistry and luciferase promoter reporter constructs. Effects of CARTp and CCK were studied on food intake.
RESULTS: CCK stimulated CARTp release from cultured nodose neurons. CARTp replicated the effect of CCK in stimulating expression of Y2R and of CART itself in these neurons in vivo and in vitro, but not in inhibiting cannabinoid-1, melanin-concentrating hormone, and melanin-concentrating hormone-1 receptor expression. Effects of CCK on Y2R and CART expression were reduced by CART small interfering RNA or brefeldin A. Exposure of rats to CARTp increased the inhibitory action of CCK on food intake after short-, but not long-duration, fasting.
CONCLUSIONS: The actions of CCK in stimulating CART and Y2R expression in vagal afferent neurons and in inhibiting food intake are augmented by CARTp; CARTp is released by CCK from these neurons, indicating that it acts as an autocrine excitatory mediator. 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19854189      PMCID: PMC2847060          DOI: 10.1053/j.gastro.2009.10.034

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  43 in total

1.  Fourth ventricular injection of CART peptide inhibits short-term sucrose intake in rats.

Authors:  H Zheng; C Patterson; H R Berthoud
Journal:  Brain Res       Date:  2001-03-30       Impact factor: 3.252

2.  Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin.

Authors:  A Asakawa; A Inui; T Kaga; H Yuzuriha; T Nagata; N Ueno; S Makino; M Fujimiya; A Niijima; M A Fujino; M Kasuga
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

3.  A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.

Authors:  Raquel Gómez; Miguel Navarro; Belén Ferrer; José M Trigo; Ainhoa Bilbao; Ignacio Del Arco; Andrea Cippitelli; Felice Nava; Daniele Piomelli; Fernando Rodríguez de Fonseca
Journal:  J Neurosci       Date:  2002-11-01       Impact factor: 6.167

4.  Cocaine- and amphetamine-regulated transcript in the rat vagus nerve: A putative mediator of cholecystokinin-induced satiety.

Authors:  C Broberger; K Holmberg; M J Kuhar; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

5.  Characterization of the cocaine- and amphetamine-regulated transcript (CART) peptide gene promoter and its activation by a cyclic AMP-dependent signaling pathway in GH3 cells.

Authors:  Geraldina Dominguez; Anita Lakatos; Michael J Kuhar
Journal:  J Neurochem       Date:  2002-03       Impact factor: 5.372

6.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

7.  Intracerebroventricular CART peptide reduces food intake and alters motor behavior at a hindbrain site.

Authors:  S Aja; S Sahandy; E E Ladenheim; G J Schwartz; T H Moran
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-12       Impact factor: 3.619

8.  Localization of orexin-1 receptors to vagal afferent neurons in the rat and humans.

Authors:  Galina Burdyga; Simon Lal; David Spiller; Wen Jiang; David Thompson; Stephen Attwood; Shakeel Saeed; David Grundy; Andrea Varro; Rod Dimaline; Graham J Dockray
Journal:  Gastroenterology       Date:  2003-01       Impact factor: 22.682

Review 9.  Gastrointestinal satiety signals II. Cholecystokinin.

Authors:  Timothy H Moran; Kimberly P Kinzig
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-02       Impact factor: 4.052

10.  The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats.

Authors:  Yukari Date; Noboru Murakami; Koji Toshinai; Shigeru Matsukura; Akira Niijima; Hisayuki Matsuo; Kenji Kangawa; Masamitsu Nakazato
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

View more
  25 in total

1.  EGR1 Is a target for cooperative interactions between cholecystokinin and leptin, and inhibition by ghrelin, in vagal afferent neurons.

Authors:  Guillaume de Lartigue; Gyorgy Lur; Rod Dimaline; Andrea Varro; Helen Raybould; Graham J Dockray
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

2.  Effect of ghrelin receptor antagonist on meal patterns in cholecystokinin type 1 receptor null mice.

Authors:  Jennifer Lee; Elizabeth Martin; Gabriel Paulino; Guillaume de Lartigue; Helen E Raybould
Journal:  Physiol Behav       Date:  2011-01-26

3.  Melanocortin-4 receptor expression in different classes of spinal and vagal primary afferent neurons in the mouse.

Authors:  Laurent Gautron; Charlotte E Lee; Syann Lee; Joel K Elmquist
Journal:  J Comp Neurol       Date:  2012-12-01       Impact factor: 3.215

Review 4.  Gut feelings: the emerging biology of gut-brain communication.

Authors:  Emeran A Mayer
Journal:  Nat Rev Neurosci       Date:  2011-07-13       Impact factor: 34.870

5.  Expression of cannabinoid CB1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype.

Authors:  Galina Burdyga; Andrea Varro; Rod Dimaline; David G Thompson; Graham J Dockray
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-04-29       Impact factor: 4.052

6.  Impaired intestinal afferent nerve satiety signalling and vagal afferent excitability in diet induced obesity in the mouse.

Authors:  Donna M Daly; Sung Jin Park; William C Valinsky; Michael J Beyak
Journal:  J Physiol       Date:  2011-03-21       Impact factor: 5.182

Review 7.  What goes around comes around: novel pharmacological targets in the gut-brain axis.

Authors:  Camila González-Arancibia; Jorge Escobar-Luna; Camila Barrera-Bugueño; Camilo Díaz-Zepeda; María P González-Toro; Loreto Olavarría-Ramírez; Francesca Zanelli-Massai; Martin Gotteland; Javier A Bravo; Marcela Julio-Pieper
Journal:  Therap Adv Gastroenterol       Date:  2016-02-17       Impact factor: 4.409

Review 8.  Role of the vagus nerve in the development and treatment of diet-induced obesity.

Authors:  Guillaume de Lartigue
Journal:  J Physiol       Date:  2016-05-29       Impact factor: 5.182

Review 9.  Putative roles of neuropeptides in vagal afferent signaling.

Authors:  Guillaume de Lartigue
Journal:  Physiol Behav       Date:  2014-03-18

10.  Vagal afferent NMDA receptors modulate CCK-induced reduction of food intake through synapsin I phosphorylation in adult male rats.

Authors:  Carlos A Campos; Hiroko Shiina; Michael Silvas; Stephen Page; Robert C Ritter
Journal:  Endocrinology       Date:  2013-05-28       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.